v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' DEFICIT (UNAUDITED) - USD ($)
Common Shares
Retroactive application of recapitalization
Common Shares
Members
Series A
As Previously Reported
Members
Series A
Retroactive application of recapitalization
Members
Series A
Members
Series B units
As Previously Reported
Members
Series B units
Retroactive application of recapitalization
Members
Series B units
Members
Series C
As Previously Reported
Members
Series C
Retroactive application of recapitalization
Members
Series C
Additional Paid-In Capital
Accumulated Deficit
As Previously Reported
Accumulated Deficit
Retroactive application of recapitalization
Accumulated Deficit
As Previously Reported
Total
Balance as of beginning at Dec. 31, 2022                             $ (121,659,065)   $ (121,659,065)
Balance as of beginning (in units) at Dec. 31, 2022         245,300     9,590,106     1,336,067            
STATEMENTS OF MEMBERS' DEFICIT                                  
Adjustment to shareholder receivables                       $ (10,116)         (10,116)
Share-based compensation                       99,365         99,365
Share-based compensation (in shares)               316,721     248,260            
Preferred A Unit dividend                       (89,249)     (1,993,027)   (2,082,276)
Net income (loss)                             (35,532,791)   (35,532,791)
Balance as of ending at Dec. 31, 2023 $ 454 $ 454                     $ (159,184,883) $ (454) (159,184,883) $ (159,184,883) (159,184,883)
Balance as of ending (in units) at Dec. 31, 2023 4,584,273   245,300 (245,300) 245,300 9,906,827 (9,906,827) 9,906,827 1,584,327 (1,584,327) 1,584,327            
STATEMENTS OF MEMBERS' DEFICIT                                  
Adjustment to shareholder receivables                       (630)         (630)
Preferred A Unit dividend                       630     (545,989)   (545,359)
Net income (loss)                             (18,437,453)   (18,437,453)
Balance as of ending at Mar. 31, 2024   $ 454                         (178,168,779)   (178,168,325)
Balance as of ending (in units) at Mar. 31, 2024   4,584,273                              
Balance as of beginning at Dec. 31, 2023 $ 454 $ 454                     (159,184,883) (454) (159,184,883) (159,184,883) (159,184,883)
Balance as of beginning (in units) at Dec. 31, 2023 4,584,273   245,300 (245,300) 245,300 9,906,827 (9,906,827) 9,906,827 1,584,327 (1,584,327) 1,584,327            
STATEMENTS OF MEMBERS' DEFICIT                                  
Adjustment to shareholder receivables                       (4,113)         (4,113)
Share-based compensation                       38,486         38,486
Preferred A Unit dividend                       (34,373)     (2,225,914)   $ (2,260,287)
Reverse recapitalization transactions, net (in shares)                                 18,732,670
Net income (loss)                             (23,065,795)   $ (23,065,795)
Balance as of ending at Dec. 31, 2024 $ 1,418 $ 1,418                     $ (184,476,592) $ (1,418) (184,476,592) $ (184,476,592) (184,476,592)
Balance as of ending (in units) at Dec. 31, 2024 14,184,397 14,184,397 245,300 (245,300) 245,300 9,906,827 (9,906,827) 9,906,827 1,584,327 (1,584,327) 1,584,327            
STATEMENTS OF MEMBERS' DEFICIT                                  
Conversion of debt to common shares   $ 225                   7,917,711         7,917,936
Conversion of debt to common shares (in shares)   2,248,945                              
Issuance of common shares for the settlement of accounts payable   $ 110                   2,567,242         2,567,352
Issuance of common shares for the settlement of accounts payable (in shares)   1,101,868                              
Issuance of common shares in connection with non-redemption agreements   $ 40                   901,049         901,089
Issuance of common shares in connection with non-redemption agreements (in shares)   404,076                              
Settlement of derivative liabilities into common shares   $ 259                   5,906,181         5,906,440
Settlement of derivative liabilities into common shares (in shares)   2,593,000                              
Common shares issued in exchange for cash   $ 30                   999,970         $ 1,000,000
Common shares issued in exchange for cash (in shares)   303,951                             6,876,840
Share-based compensation   $ 23                   470,228         $ 470,250
Share-based compensation (in shares)   225,000                              
Reverse recapitalization transactions, net   $ 455                   112,464,679         112,465,134
Reverse recapitalization transactions, net (in shares)   4,548,273                              
Net income (loss)                             (2,687,437)   (2,687,437)
Balance as of ending at Mar. 31, 2025   $ 2,561                   $ 131,227,060     $ (187,165,447)   $ (55,935,827)
Balance as of ending (in units) at Mar. 31, 2025   25,609,510